Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report

Clarithromycin is an efficacious treatment for myeloma in combination with other anti-myeloma therapy but not as monotherapy. To date, all studies have focused on a clarithromycin-specific effect rather than a...

https://ift.tt/2wq61PY